Acusphere (NASDAQ: ACUS) is a specialty pharmaceuticals company that develops new drugs and improved formulations of existing drugs using its propriety porous microparticle technology. Current product candidates are designed to address large, unmet clinical needs in the areas of cardiology, oncology, and asthma. IPO: October 2003.